These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23346156)

  • 21. Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.
    Novak MJ; Warren JD; Henley SM; Draganski B; Frackowiak RS; Tabrizi SJ
    Brain; 2012 Apr; 135(Pt 4):1165-79. PubMed ID: 22505631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent cognitive trajectories in early stage Huntington's disease: A 3-year longitudinal study.
    Martínez-Horta S; Perez-Perez J; Oltra-Cucarella J; Sampedro F; Horta-Barba A; Puig-Davi A; Pagonabarraga J; Kulisevsky J
    Eur J Neurol; 2023 Jul; 30(7):1871-1879. PubMed ID: 36994811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.
    Li HL; Li XY; Dong Y; Zhang YB; Cheng HR; Gan SR; Liu ZJ; Ni W; Burgunder JM; Yang XW; Wu ZY
    Aging Dis; 2019 Oct; 10(5):1003-1011. PubMed ID: 31595198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
    Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
    Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease Model.
    Landles C; Milton RE; Ali N; Flomen R; Flower M; Schindler F; Gomez-Paredes C; Bondulich MK; Osborne GF; Goodwin D; Salsbury G; Benn CL; Sathasivam K; Smith EJ; Tabrizi SJ; Wanker EE; Bates GP
    Brain Commun; 2020; 2(2):fcaa066. PubMed ID: 32954323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive decline in Huntington's disease expansion gene carriers.
    Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
    Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations between triplet repeat expansion and clinical features in Huntington's disease.
    Claes S; Van Zand K; Legius E; Dom R; Malfroid M; Baro F; Godderis J; Cassiman JJ
    Arch Neurol; 1995 Aug; 52(8):749-53. PubMed ID: 7639626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.
    Chen CM; Wu YR; Chang KH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular analysis of the IT15 gene in 79 Spanish families with Huntington's disease: diagnostic confirmation and presymptomatic diagnosis].
    Sánchez A; Milà M; Castellví-Bel S; Calopa M; Genís D; Jiménez D; Estivill X
    Med Clin (Barc); 1997 May; 108(18):687-90. PubMed ID: 9324583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetics of Huntington's disease].
    Goto J; Masuda N; Watanabe M; Kanazawa I
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease.
    Schultz JL; Moser AD; Nopoulos PC
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
    Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
    J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
    Vuillaume I; Vermersch P; Destée A; Petit H; Sablonnière B
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):758-62. PubMed ID: 9647305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of CAG repeat expansion in Huntington's disease gene (IT 15) in a Hungarian population.
    Jakab K; Gárdián G; Endreffy E; Kalmár T; Bachrati C; Vécsei L; Raskó I
    Eur Neurol; 1999; 41(2):107-10. PubMed ID: 10023115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
    Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
    Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.